3-Benzofurancarboxamide, 2-(4-fluorophenyl)-N-methyl-5-(1-methylethoxy)-6-[(methylsulfonyl)amino]- is a synthetic organic compound characterized by its complex structure, which includes a benzofuran moiety, a fluorophenyl group, and a methylsulfonylamino substituent. The presence of the benzofuran ring contributes to its potential biological activity, as this structural motif is often associated with various pharmacological properties. The compound features a carboxamide functional group, which can influence its solubility and reactivity. The fluorine atom in the para position of the phenyl ring may enhance lipophilicity and metabolic stability, while the methoxy group can affect the compound's electronic properties. Additionally, the methylsulfonylamino group may impart unique interactions with biological targets. Overall, this compound's intricate structure suggests potential applications in medicinal chemistry, particularly in the development of pharmaceuticals targeting specific biological pathways. However, detailed studies would be necessary to fully elucidate its properties and potential uses.

HCV-086 is a RNA-directed RNA polymerase (NS5B) inhibitor for the treatment of HCV infection.

3-BenzofurancarboxaMide, 2-(4-fluorophenyl)-N-Methyl-5-(1-Methylethoxy)-6-[(Methylsulfonyl)aMino]-

691852-36-5: 3-Benzofurancarboxamide, 2-(4-fluorophenyl)-N-methyl-5-(1-methylethoxy)-6-[(methylsulfonyl)amino]- is a synthetic organic compound characterized by its complex structure, which includes a benzofuran moiety, a fluorophenyl group, and a methylsulfonylamino substituent. The presence of the benzofuran ring contributes to its potential biological activity, as this structural motif is often associated with various pharmacological properties. The compound features a carboxamide functional group, which can influence its solubility and reactivity. The fluorine atom in the para position of the phenyl ring may enhance lipophilicity and metabolic stability, while the methoxy group can affect the compound's electronic properties. Additionally, the methylsulfonylamino group may impart unique interactions with biological targets. Overall, this compound's intricate structure suggests potential applications in medicinal chemistry, particularly in the development of pharmaceuticals targeting specific biological pathways. However, detailed studies would be necessary to fully elucidate its properties and potential uses.

<p>HCV-086, a RNA-directed RNA polymerase (NS5B) inhibitor, is used for the treatment of HCV infection.</p>

CAS 691852-36-5

3-BenzofurancarboxaMide, 2-(4-fluorophenyl)-N-Methyl-5-(1-Methylethoxy)-6-[(Methylsulfonyl)aMino]-

HCV-086

Ref: TM-T27530